Roche BPA, pimc
Ended Awarded
- Contract number
- 75H71221A00014
- Awardee
-
Roche Diabetes Care Inc. UEI F6JDDN8L9JM4
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Task orders
- 7 $1,656,480 obligated
Award facts
- Opportunity
-
- RFQ1518501 Solicitation number
- Combined order value
- $1,607,612 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 83% used
- $2,000,000.00
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services Indian Health Service awarded a blanket purchase agreement to Roche Diabetes Care Inc. for the provision of diabetic testing supplies. The IDV has a potential value of $2 million and was awarded on September 23, 2021 without a set-aside designation. Under the IDV, three BPA calls have been awarded to Roche for diabetic testing supplies at the Phoenix Indian Medical Center and Castleton, Indiana locations. The calls have values ranging from $250,000 to $250,000 and completion dates from September 2022 through November 2023. Roche will provide the supplies through its Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits.
The BPA calls aim to procure diabetic testing supplies to support the Indian Health Service's diabetes management and care programs serving American Indian and Alaska Native populations. The IDV and associated calls are awarded on a firm-fixed price basis to Roche's GSA schedule contract for diagnostic products. The IDV and calls allow the Indian Health Service to fulfill its mission of providing healthcare services tailored to address the medical needs of native communities through contracted provision of diabetic supplies.
Task orders
Quick answers
Who was awarded contract 75H71221A00014?
75H71221A00014 was awarded to Roche Diabetes Care Inc. by Indian Health Service (Department of Health and Human Services) on September 23, 2021.
How much is contract 75H71221A00014 worth?
Orders under 75H71221A00014 have obligated $1,656,480. Their combined current value, with exercised options, is $1,607,612. 75H71221A00014's own ceiling is $2,000,000. A single order can be worth up to $250,000.
How many orders have been placed under contract 75H71221A00014?
7 orders have been placed under 75H71221A00014, the latest on September 27, 2026.
Who can order from contract 75H71221A00014?
75H71221A00014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75H71221A00014 under another contract?
Yes. 75H71221A00014 is a blanket purchase agreement under V797D50597, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75H71221A00014 competed?
The extent of competition for 75H71221A00014 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV